Nuwellis (NASDAQ: NUWE) has announced the appointment of Carisa Schultz as chief financial officer (CFO), effective February 2, 2026.
Ms. Schultz brings extensive healthcare and public company finance leadership experience, including early career experience at Boston Scientific and most recently as VP of finance at NeueHealth.
In a statement, John Erb, Chief Executive Officer of Nuwellis, commented, “Carisa is a highly accomplished financial leader with strong public-company experience and a deep understanding of healthcare and medical technology. Her expertise and disciplined approach will be instrumental as we continue to execute our strategy and advance our cardiorenal platform.”
